Alpha-tocopherol ameliorates experimental autoimmune encephalomyelitis through the regulation of Th1 cells

Document Type: Original Article


1 Department of Clinical Laboratory, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450002, China

2 Key Clinical Laboratory Medicine of Henan Province, Zhengzhou 450002, China

3 Department of Laboratory Medicine, Zhengzhou University, Zhengzhou, Henan 450002, China

4 Key Laboratory of the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan450002, China


Objective(s): Multiple sclerosis (MS) is a serious neurological autoimmune disease, it commonly affects young adults. Vitamin E (Vit E) is an important component of human diet with antioxidant activity, which protects the body’s biological systems. In order to assess the effect of Vit E treatment on this autoimmune disease, we established experimental autoimmune encephalomyelitis (EAE), the animal model of MS, and treated EAE with α-tocopherol (AT) which is the main content of Vit E.
Materials and Methods:Twenty C57BL/6 adult female mice were used and divided into two groups randomly. EAE was induced with myelin oligodendrocyte glycoprotein (MOG), and one group was treated with AT, at a dose of 100 mg/kg on the 3th day post-immunization with MOG, the other group was treated with 1% alcohol. Mice were euthanized on day 14, post-immunization, spleens were removed for assessing splenocytes proliferation and cytokine profile, and spinal cords were dissected to assess the infiltration of inflammatory cells in spinal cord.
Results:AT was able to attenuate the severity of EAE and delay the disease progression. H&E staining and fast blue staining indicated that AT reduced the inflammation and the demyelination reaction in the spinal cord. Treatment with AT significantly decreased the proliferation of splenocytes. AT also inhibited the production of IFN-γ (Th1 cytokine), though the other cytokines were only affected slightly.
Conclusion:According to the results, AT ameliorated EAE, through suppressing the proliferation of T cells and the Th1 response. AT may be used as a potential treatment for MS.


1.Dyment DA, Ebers GC, Sadovnick AD. Genetics of multiple sclerosis. Lancet Neurol 2004; 3:104-110.

2.Compston A, Coles A. Multiple sclerosis. Lancet 2008; 372:1502-15017.

3.Baxter AG. The origin and application of experimental autoimmune encephalomyelitis. Nat Rev Immunol 2007; 7:904-912.

4.Stromnes IM, Goverman JM. Passive induction of experimental allergic encephalomyelitis. Nat Protoc 2006; 1:1952-1960.

5.Stromnes IM, Goverman JM. Active induction of experimental allergic encephalomyelitis. Nat Protoc 2006; 1:1810-1819.

6.Zhu J, Paul WE. Heterogeneity and plasticity of T helper cells. Cell Res 2010; 20:4-12.

7.Wan YY, Flavell RA. How diverse--CD4 effector T cells and their functions. J Mol Cell Biol 2009; 1:20-36.

8.Korn T, Anderson AC, Bettelli E, Oukka M. The dynamics of effector T cells and Foxp3+ regulatory T cells in the promotion and regulation of autoimmune encephalomyelitis. J Neuroimmunol 2007; 191:51-60.

9.Sundram K, Sambanthamurthi R, Tan YA. Palm fruit chemistry and nutrition. Asia Pac J clin Nutr 2003; 12:355-362.

10.Evans HM, Bishop KS. On the existence of a hitherto unrecognized dietary factor essential for reproduction. Science 1922; 56:650-651.

11.Mirbagheri SA, Nezami BG, Assa S, Hajimahmoodi M. Rectal administration of d-alpha tocopherol for active ulcerative colitis: a preliminary report. World J Gastroenterol 2008; 14:5990-5995.

12.Isozaki Y, Yoshida N, Kuroda M, Takagi T, Handa O, Kokura S, et al. Effect of a novel water-soluble vitamin E derivative as a cure for TNBS-induced colitis in rats. Int J Mol Med 2006; 17:497-502.

13.Meydani M, Macauley JB, Blumberg JB. Effect of dietary vitamin E and selenium on susceptibility of brain regions to lipid peroxidation. Lipids 1988; 23:405-409.

14.Haleagrahara N, Swaminathan M, Chakravarthi S, Radhakrishnan A. Therapeutic efficacy of vitamin E delta-tocotrienol in collagen-induced rat model of arthritis. Bio Med Res Int 2014; 2014:539540.

15.Abdala-Valencia H, Berdnikovs S, Soveg FW, Cook-Mills JM. alpha-Tocopherol supplementation of allergic female mice inhibits development of CD11c+CD11b+ dendritic cells in utero and allergic inflammation in neonates. Am J Physiol Lung Cell  Mol Physiol 2014; 307:L482-496.

16.Blanchard B, Heurtaux T, Garcia C, Moll NM, Caillava C, Grandbarbe L, et al. Tocopherol derivative TFA-12 promotes myelin repair in experimental models of multiple sclerosis. J Neurosci 2013; 33:11633-11642.

17.Goverman J. Autoimmune T cell responses in the central nervous system. Nat Rev Immunol 2009; 9:393-407.

18.Kasper LH, Shoemaker J. Multiple sclerosis immunology: The healthy immune system vs the MS immune system. Neurology 2010; 74:S2-8.

19.Sorensen PS, Koch-Henriksen N, Bendtzen K. Are ex vivo neutralising antibodies against IFN-beta always detrimental to therapeutic efficacy in multiple sclerosis? Mult Scler 2007; 13:616-621.

20.DeAngelis T, Lublin F. Multiple sclerosis: new treatment trials and emerging therapeutic targets. Curr Opin Neurol 2008; 21:261-271.

21.Yang CS, Lu G, Ju J, Li GX. Inhibition of inflammation and carcinogenesis in the lung and colon by tocopherols. Ann N Y Acad Sci 2010; 1203:29-34.

22.Tahan G, Aytac E, Aytekin H, Gunduz F, Dogusoy G, Aydin S, et al. Vitamin E has a dual effect of anti-inflammatory and antioxidant activities in acetic acid-induced ulcerative colitis in rats. Can J Surg 2011; 54:333-338.

23. Nazrun AS, Norazlina M, Norliza M, Nirwana SI. The anti-inflammatory role of vitamin e in prevention of osteoporosis. Advances in pharmacological sciences. 2012;2012:142702.

24.Kapelusiak-Pielok M, Adamczewska- Goncarzewicz Z, Dorszewska J,Grochowalska A. The protective action of alpha-tocopherol on the white matter lipids during moderate hypoxia in rats. Folia Neuropathol 2005; 43:103-108.

25.Sheridan PA, Beck MA. The dendritic and T cell responses to herpes simplex virus-1 are modulated by dietary vitamin E. Free Radic Biol Med 2009; 46:1581-1588.

26.Singh U, Devaraj S, Jialal I. Vitamin E, oxidative stress, and inflammation. Annu Rev Nutr 2005; 25:151-174.

27.Munteanu A, Zingg JM, Azzi A. Anti-atherosclerotic effects of vitamin E--myth or reality? J Cell Mol Med 2004; 8:59-76.